Program

The scientific program


Please note that this is a preliminary program and may be subject to change.
 

27TH OF JUNE - WEDNESDAY

Time
18.00-20.00 CONFERENCE OPENING AND WELCOME RECEPTION                                                           
m
 

28TH OF JUNE - THURSDAY

Time Symposium
n
07.15-08.00           Satellite symposium
n
08.15-08.35 OPENING CEREMONY
Prof. Mona Ståhle, President of the Conference
Department of Medicine, Dermatology and Venereology unit, Karolinska Universitetssjukhuset, Solna, Sweden
Mr. Lars Ettarp President of the International Federation of Psoriasis Associations, Stockholm, Sweden
08.35-10.30 PLENARY SESSION I - Immunology
n
Rethinking inflammation: neural circuits in control of immunity
Dr Peder Olofsson, Senior researcher, Department of Medicine
n
Immunological principles in psoriasis and psoriatic arthritis
Prof. Dr. Jörg Prinz, Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany
n
Immunological principles in psoriasis and psoriatic arthritis
Dr. Christopher Ritchlin, Professor, Department of Medicine Allergy/Immunology and Rheumatology,
University of Rochester, USA
n
Discussion and Q & A Session with session speakers
n
10.00-10.30 Coffee/Posters/Exhibits
m
10.30-11.10 KEYNOTE LECTURE 1 - Treat to target – but what is the target?
Prof. Dr. Peter van de Kerkhof, Professor Faculty of Medicine, Chair Dermatology, Radboud University, Nijmegen, The Netherlands
m
11.10-12.00 INTERACTIVE SESSION WITH TWO CASE PRESENTATIONS
n
CASE 1 - Differential response to treatment (skin vs joints)
Dr Laura Coates, NIHR Clinician Scientist and Senior Clinical Research Fellow, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, United Kingdom
Case discussion, Q & A session
n
CASE 2 - Case topic to be confirmed
Speaker tbc
Case discussion, Q & A session
n
12.00-13.30 Lunch/Posters/Exhibits
n
12.15-13.15 Satellite symposium
n
13.30-15.10 PLENARY SESSION 2 - Psoriasis and psoriatic arthritis treatment and care around the world - regional overview
n
Africa
Prof. Dr. Mahira Hamdy El-Sayed, Professor of Dermatology, Venereology and Andrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
n
AsiaPacific
Dr Colin Theng, Medical Director and Consultant Dermatologist Mt Alvernia Medical Centre, Singapore
n
Middle East
Prof. Ori Elkayam, Director, The Institute of Rheumatology, Tel-Aviv-Sourasky Medical Center, Israel
n
Latin America
Dr Enrique Soriano, Head of Rheumatology, Department of Clinical Medicine, Hospital Italiano de Buenos Aires, Argentina
n
Panel discussion with Q & A session
 
15.10-15.30 ABSTRACT SESSION 1 - Oral abstract presentations
n
15.30-16.00 Coffee/Posters/Exhibits
n
16.00-16.40 KEYNOTE LECTURE 2 - The Global Psoriasis Atlas: a tool to address unmet needs in psoriasis
Prof. Christopher Griffiths, Foundation Professor of Dermatology University of Manchester; Consultant Dermatologist at Salford Royal NHS Foundation Trust, Manchester, United Kingdom
17.00-18.00 Satellite Symposium
m
 

29TH OF JUNE - FRIDAY

Time Symposium
07.30-08.15          Satellite symposium
m
08.30-09.40 PLENARY SESSION 3 - Diagnostics – biomarkers and clinical indicators:
n
Biomarkers in psoriasis and psoriatic arthritis
Dr Vinod Chandran, Associate Professor at the University of Toronto, Affiliate Scientist Krembil Research Institute, Canada
Early detection of psoriatic arthritis in psoriasis patients
Dr Joseph Merola, Associate Physician, Brigham and Women's Hospital; Assistant Professor of Dermatology, Harvard Medical School, USA
S
Discussion with Q & A session
09.40-10.00 ABSTRACT SESSION 2 - Oral abstract presentations
m
10.00-10.30 Coffee/Posters/Exhibits
m
10.30-12.00 PLENARY SESSION 4 - Challenges in disease management
n
Addressing well-being: The overlooked element in psoriatic diseases
Dr Elaine Husni, Vice Chair of Rheumatology and Director of the Arthritis and Musculoskeletal Center the Cleveland Clinic; Assistant Professor Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, USA
 
Management of psoriasis/psoriatic arthritis before, during and after pregnancy
Dr Arthur Kavanaugh, Professor of Clinical Medicine, Director, Center for Innovative Therapy, UC San Diego School of Medicine, USA
 
Management of psoriasis in the pediatric population
Dr Marieke Seyger, Associate Professor Department of Dermatology, Radboud University, Nijmegen, The Netherlands
 
11.10-12.00 INTERACTIVE SESSION WITH TWO CASE PRESENTATIONS 
m
CASE 1 - Presentation of a challenging paediatric psoriasis case
Dr Josefin Lysell, Department of Medicine, Dermatology and Venereology Unit, Karolinska Universitetssjukhuset, Solna, Sweden
 
CASE 2 - Presentation of a challenging case – psoriasis/psoriatic arthritis during pregnancy: Pregnant female with severe flare of skin and joints – treatment options
Dr Abby Van Voorhees, Professor and Chair, Dermatology, Eastern Virginia Medical School, Norfolk, USA
12.00-13.30 Lunch/Posters/Exhibits
m m
12.15-13.15 Satellite symposium
m m
13.30-15.30 PLENARY SESSION 5 - Treatment guidelines and outcomes measures
m m
Current treatment guidelines for psoriasis and psoriatic arthritis
Dr Laura Coates, NIHR Clinician Scientist and Senior Clinical Research Fellow, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom
n
Outcomes measures in psoriasis and psoriatic arthritis – a comprehensive review
Kristina Callis Duffin, Associate Professor of Dermatology at the University of Utah, Salt Lake City, USA
OPEN MIKE SESSION - The ideal treatment – what is it and is it possible to attain? 
 
Moderator: Prof. Dr. Kilian Eyerich, Assistant Professor Experimental Dermato-Immunology, School of Medicine, Technische Universität München, Germany

Panelists: Prof. Dr. Ulrich Mrowietz, Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany, Dr Philip Helliwell, Senior Lecturer in Rheumatology University of Leeds; Honorary Consultant Rheumatologist Bradford Hospitals NHS Trust, Leeds, United Kingdom, Ms Silvia Fernandez Barrio, Board member International Federation of Psoriasis Associations, Argentina, Mr. Ingvar August Ingvarsson, Board member International Federation of Psoriasis Associations, Iceland
 
15.30-16.00 Coffee/Posters/Exhibits
m
16.00-16.40 The virtual doctor: Working in a virtual treatment environment
Dr Luis Mazzuoccolo, Head of Dermatology Services, Department of Dermatology, Hospital Italiano de Buenos Aires, Argentina
 
17.00-18.00 Satellite Symposium
M
 

30TH OF JUNE - SATURDAY

Time Symposium
m
07.30-08.15           Satellite symposium
                    
08.30–09.20 PLENARY SESSION 6 - Treatment session
 Management of low-to-moderate psoriasis severity
Prof. Dr. Jo Lambert, Academic Department Head, Full professor, Department of Dermatology, Ghent University, Belgium
 
New to market - an overview
Prof. Lars Iversen, Clinical professor and Chair, Department of Clinical Medicine - The Department of Dermatology and Venereology, Aarhus University, Denmark
 
Panel discussion with Q & A session
 
09.20-10.00 INTERACTIVE SESSION WITH INTERESTING CLINICAL CASES - focus on management of  comobidities
M
CASE 1: Treatment of psoriasis and severe infection
Dr Hoseah Waweru, Vice President International Federation of Psoriasis Associations
Department of Dermatology, Upper Hill Medical Centre, Nairobi, Kenya

 
Case discussion
 
CASE 2: Concomitant neoplasm
Dr Paolo Gisondi, Adjunct Professor, Department of Medicine, Section of Dermatology and Venereology, University of Verona, Italy
 
Case discussion
 
10.00-10.30 Coffee/Posters/Exhibits
m
10.30-11.10 KEYNOTE LECTURE 4 - 15 years of biologic treatment of psoriasis and psoriatic arthritis - long-term afficacy and safety
m
Psoriasis and biologics
Dr. Alice Gottlieb, Chair Dermatology Research Unit Tufts Medical Center, Harvey B. Ansell Professor of Dermatology, Tufts University, Boston, USA
 
Psoriatic arthritis and biologics
Dr. Dafna Gladman, Professor of Medicine at the University of Toronto, Senior Scientist Toronto Western Research Institute, Canada
 
11.10-12.00 PLENARY SESSION 7 - Biosimilars
m
How original is the original?
Dr Arnon Cohen, Senior lecturer, Faculty of Health Sciences, Department of Community Health, Ben-Gurion University of the Negev, Israel
 
Recommendations for usage of biosimilars
Prof. Lone Skov, Professor and Senior Physician, Herlev and Gentofte Hospital, Department of Dermatology and Allergy, University of Copenhagen, Denmark
 
Panel discussion with Q & A session
 
12.00-13.30 Lunch/Posters/Exhibits
12.15-13.15 Satellite symposium
13.30-15.00 PLENARY SESSION 8 - Comorbidities associated with psoriasis and psoriatic arthritis
m
Overview of comorbidity profiles and screening recommendations
Prof. Luigi Naldi, Professor of Dermatology, Department of Dermatology, Azienda Ospedaliera papa Giovanni XXIII, Director Centro Studi GISED, Bergamo, Italy
 
The gut-joint axis in psoriatic arthritis
Dr Francesco Ciccia, Division of Rheumatology, Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Italy
 
Psoriasis, psoriatic arthritis and cardiovascular disease
Dr. Nehal Mehta, Lasker Clinical Research Scholar, Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung and Blood Institute, Bethesda, USA
 
Psoriasis, psoriatic arthritis and the brain
Dr. Jashin Wu, Director of Dermatology research, Kaiser Permanente Los Angeles Medical Center, Los Angeles, USA
 
Discussion
15.00-15.30 Coffee/Posters/Exhibits
15.30-16.10 KEYNOTE LECTURE 5 - Is an integrated psoriasis care possible – or just an utopian patient dream?
Dr. Abrar Qureshi, Chair, Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, USA
16.10-16.30 CLOSING LECTURE - The Global Psoriasis Coalition and the way forward
Mr Lars Ettarp
President International Federation of Psoriasis Associations, Stockholm, Sweden
16.30-16.45 Closing of scientific program
Prof. Mona Ståhle

The International Federation of Psoriasis Associations is a non-profit organization representing over 125 million people living with psoriasis or psoriatic arthritis worldwide.

IFPA Secretariat
Gustavslundsvägen 143
167 51 Bromma, SWEDEN